Conjugates of Immune Cell Specific Macrolide Compounds with Anti-Inflammatory Compounds for Improved Cellular Targeting of Anti-Inflammatory Therapy
申请人:MERCEP Mladen
公开号:US20090105163A1
公开(公告)日:2009-04-23
The present invention relates to novel compounds represented by the structure I and pharmaceutical preparations thereof for the treatment of inflammatory diseases in humans and animals.
本发明涉及一类由结构式I表示的新化合物及其制药制剂,用于治疗人和动物的炎症性疾病。
CONJUGATES OF IMMUNE CELL SPECIFIC MACROLIDE COMPOUNDS WITH ANTI-INFLAMMATORY COMPOUNDS FOR IMPROVED CELLULAR TARGETING OF ANTI-INFLAMMATORY THERAPY
申请人:GlaxoSmithKline istrazivacki centar Zagreb d.o.o.